SYROS PHARMACEUTICALS INC (SYRS) Stock News
NASDAQ:SYRS - Nasdaq - US87184Q2066 - Common Stock - Currency: USD
SYRS Latest News, Press Relases and Analysis
All
Press Releases
a month ago - Rege Nephro CO., Ltd.
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
/PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired...
2 months ago - Benzinga
Dow Dips Over 200 Points; US Industrial Production Increases More than Expected